immune suppression in goldfish (11) . A meta-analysis reveals that ATR exposure consistently compromises the immune function of fish and amphibians (5) . Brodkin et al. reported that in frogs ATR exposure suppressed the thioglycollate-stimulated recruitment of white blood cells to the peritoneal cavity compared to the background levels and also decreased the phagocytic activity of these cells (10) . Langerveld et al. reported that ATR altered the expression of genes associated with growth and metabolism, proteolysis, fibrinogen complex formation, and immune regulation (14) . A significant decrease in the number of intracelomatic cells and a significant decrease in the phagocytic index are observed after ATR exposure. In addition, silver catfish fingerlings exposed to ATR are more susceptible to intracelomatic challenge with the pathogen Aeromonas hydrophila (15) .
Some studies have examined the immunotoxic potential of acute ATR exposure in adult animals. Exposure to ATR for 14 days can induce a significant decrease in the number of hematopoietic progenitors in murine bone marrow (16) , cause a transient suppression of IgM production and T cell proliferation (17) , decrease the CD4+ lymphocytes and MHC-II+ cells (18) , and increase the mixed lymphocyte reaction (MLR) and cytotoxic T lymphocyte (CTL) response (19) . Rajkovic et al. reported that ATR increased the number of degranulated mast cells of rats (20) . Ðikic et al. detected apoptotic cells in the thymus and lymph nodes of rats exposed to ATR (21) .
Prenatal ATR exposure often causes substantially different effects in adult offspring from those noted in adult animals that are exposed (22, 23) . In one study, Rooney et al. orally administered ATR to SpragueDawley rats from day 10 of gestation to day 23 postnatally when pups were weaned. Two weeks after weaning, male pups that were inoculated with sheep red blood cells (SRBC) had a delayed hypersensitivity response that decreased in magnitude and a decreased IgM antibody response (24) . Rowe et al. used timerelease pellets to subcutaneously expose pregnant Balb/c dams to 700 μg/day of ATR for 21 days from day 10 and day 12 of pregnancy. At 3 months of age, male, but not female, mouse pups had increases in T cell proliferation, cytolytic activity, and the number of IgM-secreting B cells in the spleen, but there were no marked changes in the body weight, organ-to-body weight ratio of the spleen, and the numbers of CD8+ T cells, CD4+ T cells, and B220+ B cells in the spleen (25) .
Previous studies described the toxic effects of atrazine on the adult and prenatal immune systems of animals. However, the immune system is still developing in the early postnatal period. The developing immune system is more sensitive to xenobiotic exposure than the adult immune system (26) (27) (28) . A continuous remodeling of the primary and secondary immune organs occurs in mice throughout their lives, i.e., a decline in the relative weight of the thymus, spleen, and lymph nodes occurs before puberty, while only the thymus continues to involute after puberty (29) . One of the proposed windows of vulnerability for the developing rodent immune system occurs postnatally, which is from day 30 to sexual maturity (30) . Combined with the limited immunotoxicity data in terms of age and with the possible impact and relevance of such data for immunotoxicological risk assessment, the current study sub-acutely exposed 4-week-old C57B l/6 mice to ATR for 28 days in order to assess the immunotoxic potential of ATR.
Materials and Methods

Chemicals and reagents
ATR (99% purity) and concanavalin A (ConA) were obtained from Sigma Chemical Company (St Louis, Missouri, USA). RPMI-1640 medium and fetal calf serum (FBS) were purchased from Gibco Laboratory (Gaithersburg, Maryland, USA). Interleukin-2 (IL-2), interleukin-4 (IL-4), interferon γ (IFN-γ), and tumor necrosis factor α (TNF-α) enzyme-linked immunosorbent assay (ELISA) kits were from R&D Systems (Minneapolis, Minnesota, USA). CD3, CD4, and CD8 fluorescence-conjugated antibody were from Ebioscience (San Diego, California, USA). ATR solutions (0.5 mg/mL, 2.5 mg/mL, and 12.5 mg/mL) were prepared by dissolving ATR in corn oil. These solutions were kept at 4ºC for a maximum of 1 week.
Animals and treatment
Male mice housed three or more per cage often fight, and this may cause unpredictable stress responses that affect the immunological parameters being studied. Thus, 4-week-old pathogen-free female C57B l/6 mice were used in this study. Animals were purchased from the Experimental Animal Center of Norman Bethune Medical College, Jilin University (Changchun, China). This study was conducted in accordance with internationally recognized guidelines and approved by the Animal Research Committee of Norman Bethune College of Medicine, Jilin University. Animals were housed in groups of five in a temperature-and humiditycontrolled environment and given access to food and water ad libitum. These animals were randomly divided into 4 groups by body weight (ten/group) and were orally given 0, 5, 25, or 125 mg/kg ATR for 28 consecutive days. Blood and the spleen and thymus were collected 24 h after the final round of ATR treatment.
Body weight and organ weight
Mice were weighed once every 7 days starting on day 1 after ATR treatment. The organs were collected aseptically and weighed on day 29. The relative weights instructions. Briefly, splenocytes were re-suspended in 100 μL of binding buffer followed by addition of 10 μL of anti-CD3-PE-Cy5, anti-CD4-FITC, or anti-CD8-PE. After incubation for 15 min at 37ºC, cells were washed thrice and then subjected to flow cytometry on the FAC Scan (Becton Dickinson Immuno-cytometry, San Jose, CA), in which 1 × 10 5 cells were counted. Analysis was performed using the CELL Quest software package (BDIS) in list mode and the lymphocyte gate as defined by forward/side scatter characteristics.
Enzyme-linked immunosorbent assay (ELISA) of IL-2, IL-4, IFN-γ, and TNF-α
After treatment with ATR for 28 days, animals were sacrificed and blood was collected. The serum was obtained by centrifugation at 3,000 g × for 10 min. The serum levels of murine IL-2, IL-4, IFN-γ, and TNF-α were detected with corresponding ELISA kits in accordance with the manufacturer's instructions.
Statistical analysis
Data were analyzed using the Statistical Package for Social Sciences (SPSS) version 10. Data were expressed as means ± standard deviations (S.D.). Comparisons among multiple groups were done using two-way analysis of variance (ANOVA). A value of p < 0.05 was considered statistically significant.
Results
General state and body weight
All animals survived to the end of study. There were no overt changes in appearance and/or behaviors and no significant differences in body weight ( Figure 1A ) after ATR exposure.
Toxic effects of ATR on the spleen
The mean weights of the spleen and thymus decreased in mice treated with 25 mg/kg ATR and 125 mg/kg ATR (p < 0.05) compared to the control group ( Figure 1B ). Histopathological examination of the spleen revealed degenerative changes. The spleens appeared atrophic in mice treated with 25 mg/kg ATR and 125 mg/kg ATR and were characterized by effacement of germinal centers, diminution of white pulp, and congestion of red pulp ( Figure 1C ). There were no significant changes in mice treated with 5 mg/kg ATR in comparison to the control group.
Lymphocyte transformation
An MTT assay was performed to evaluate splenic lymphocyte proliferation in mice treated with different of organs were calculated as organ weight (mg)/body weight (g).
Pathological examination
The spleen was collected, fixed in 10% buffered formaldehyde, embedded in paraffin, and then sectioned. The sections were stained with hematoxylineosin for histological assessment.
Preparation of splenocytes
Suspensions of single cells from the spleen were prepared by gently passing the spleen through a nylon mesh filter. Cellular debris was removed with a 400-μm stainless steel mesh. Red blood cells were lysed with a hypotonic buffered solution and lymphocytes were washed with PBS and re-suspended in RPMI-1640 medium supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM L-glutamine. Viable cells were counted using the trypan blue exclusion method with a hemocytometer.
Lymphocyte transformation test (LTT)
Freshly isolated splenocytes were suspended in complete RPMI-1640 medium supplemented with 10% FBS. The splenocytes were seeded into 6 wells in a 96-well plate (each well containing 2 × 10 4 cells). Cells in three wells were treated with PBS and served as controls, while cells in the remaining three wells were treated with 20 μg/mL ConA. After culturing in an incubator containing 5% CO 2 at 37ºC for 48 h, cell counting was done using a 3-(4,5-dimethylthiazol-2-yl) -2,5-diphe-nyltetrazolium bromide (MTT) assay. The optical density (OD) was quantified using a microplate reader. The following formula was used to calculate the stimulation index (SI): SI = OD of ConA-treated cells/OD of control cells.
Natural killer (NK) cell cytotoxicity assay
NK cells from mouse spleens were prepared as described above and used as effector cells. Mouse lymphoma YAC-1 cells, which are sensitive to NK cells, were used as target cells. Briefly, 1 × 10 4 YAC-1 cells and effector cells were separately added to a 96-well plate. After incubation for 48 h, NK cytotoxicity was assessed using the MTT assay described above. Cytotoxic activity was calculated using the following formula: NK cytotoxicity (%) = [1 -(OD E+T -OD E )/OD T × 100%]. (E + T = a mixture of effector cells and target cells, E = effector cells, T = target cells).
Flow cytometry
For cell phenotype analysis, fluorescence-conjugated antibody was used in accordance with the manufacturer's concentrations of ATR. The SI was 2.69 ± 0.21 in mice treated with 25 mg/kg ATR and 1.64 ± 0.67 in mice treated with 125 mg/kg ATR, reflecting a significant decrease compared to the SI in the control group (3.19 ± 0.10) (p < 0.05, Figures 2A) . The SI did not differ significantly in mice treated with 5 mg/kg ATR (2.66 ± 0.72) and the control group. These results suggest that ATR exposure reduced lymphocyte proliferation in mice.
NK cell cytotoxicity assay
To determine the impact of ATR on NK cell function, the activity of NK cells was measured via a cytotoxicity assay. Results indicated that NK cell cytotoxic activity was 71.16 ± 2.29% in mice treated with 125 mg/kg ATR, reflecting a significant decrease compared to the control group (85.08 ± 6.43%) (p < 0.05) (Figures 2B). Compared to the control group, there were no significant differences in the NK cell cytotoxic activity in mice treated with 25 mg/kg ATR (90.54 ± 3.23%) and 5 mg/kg ATR (84.04 ± 12.53).
Lymphocyte phenotypes in the spleen
Flow cytometry was used to detect the surface markers of lymphocytes. Results revealed that the percentage of CD3+ lymphocytes in the spleen decreased in mice treated with 25 mg/kg ATR (36.22 ± 2.62%) and 125 mg/kg ATR (34.80 ± 4.22%) compared to the control group (45.22 ± 0.55%) (p < 0.05) ( Figure 3A) . The percentage of CD4+ lymphocytes in the spleen decreased significantly in mice treated with 25 mg/kg ATR (8.39 ± 0.56%) and 125 mg/kg ATR (7.14 ± 0.88%) compared to the control group (11.08 ± 0.49%) (p < 0.05) ( Figure 3B ). Neither CD3+ (36.94 ± 7.79%) nor CD4+ (11.14 ± 1.16%) lymphocytes changed significantly in mice treated with 5 mg/kg ATR. There were no significant changes in the percentage of CD8+ lymphocytes in the groups treated with ATR and the control group. In fact, ATR treatment reduced the splenic CD4+/CD8+ ratio.
IL-2, IL-4, IFN-γ, and TNF-α
To further investigate the mechanisms by which ATR inhibits NK activation and decreases T lymphocytes, the serum levels of pro-inflammatory and immunosuppressive cytokines such as IL-2, IL-4, IFN-γ, and TNF-α were detected. As shown in Figure 4A , IL-2 levels in mice treated with ATR were comparable to those in the control group (p > 0.05), and the serum level of IL-2 was 330.88 ± 50.40 in mice treated with 0 mg/kg ATR, 307.24 ± 58.35 in mice treated with 5 mg/kg ATR, 322.70 ± 53.38 in mice treated with 25 mg/kg ATR, and 330.42 ± 53.05 in mice treated with 125 mg/kg ATR. As shown in Figure 4B , the IL-4 levels in mice treated with 25 mg/kg ATR (16.93 ± 1.14 ng/mL) and 125 mg/kg ATR (17.25 ± 1.98 ng/mL) had decreased about 15% from levels in the control group (20.45 ± 2.56 ng/mL) (p < 0.05), while there were no significant differences in those levels in mice treated with 5 mg/kg ATR (18.03 ± 2.50 ng/mL) and the control group. Figure 4C shows that IFN-γ levels in mice treated with ATR were similar to those in the control group (p > 0.05). The serum level of IFN-γ was 131.58 ± 40.95 
Discussion
The immune system is a complex network of interacting regulatory genes, hormones, and cells that has evolved in multicellular organisms for the purpose of maintaining homeostasis against a dynamic battery of foreign environmental agents and/or pathogens. Environmental pollutants can interfere with the normal operation of the immune system, leading to a broad range of disorders, including endocrine dysfunction, tumorigenesis, increased rates of inflammatory infections, and autoimmune diseases. Widespread use of the herbicide ATR increases the chance for and rate of exposure to other foreign agents that the immune system must contend with, and yet the immunotoxicological potential of ATR has not been studied extensively. The present study sought to examine the effects of ATR on selected immune parameters in juvenile mice. ATR (up to 125 mg/kg per day) was orally administered to 4-week-old female C57BL/6 mice for 28 days. One day after the final round of ATR treatment, mice were sacrificed and their serum and spleens were collected.
During the experiment, overt changes in the appearance and behaviors were not observed in mice treated with ATR, and no significant difference in body weight was noted after ATR exposure. However, relative spleen and thymus weights decreased significantly in mice treated with 25 mg/kg ATR and 125 mg/kg ATR compared to the control group, but there were no significant changes in those weights in mice treated with 5 mg/kg ATR. Since abnormal weights of the spleen and thymus are important indicators used to investigate immunotoxic potential (9), the current results indicate that ATR was likely to be immunotoxic to juvenile mice. The decrease in immune organ weight may be associated with the inhibition of lymphocyte proliferation and/or the increase in lymphocyte death in the spleen and thymus (9) . In the current study, the histopathological features of the spleen were detected by light microscopy, and results revealed degenerative changes, compared to the control group, in the spleens of mice treated with 25 mg/kg ATR and 125 mg/kg ATR but not in mice treated with 5 mg/kg ATR. These results suggested that ATR exposure had an adverse impact on the immunity of the spleen in mice. This conclusion is supported by other studies reporting the adverse effects of ATR on the immune system (18) .
T cells play a central role in organizing the immune defense and are practically involved in all types of immune reactions either by orchestrating the type of immune response or as effectors themselves (31) . ConA is one of the biologically relevant stimuli applied to activate lymphocytes (32) . In order to understand the effects of ATR induced T-cell response, the ability of ConA to stimulate the proliferation of T lymphocytes was investigated 1 day after the final round of ATR treatment. Results indicated that 5 mg/kg ATR induced similar T-cell proliferation in the control group while the SI of lymphocytes decreased significantly in mice treated with 25 mg/kg ATR and 125 mg/kg ATR in comparison to the control group. These findings suggest that ATR exposure for 28 days could lead to the inhibition of T-cell proliferation. NK cells play a central role in the immune defense against tumor development and viral infections. Thus, any agent that interferes with the ability of NK cells to lyse their targets may increase the risk for tumorigenesis and/or viral infections (1) . To determine the impact of ATR on NK cell function, the antitumor activity of NK cells was detected via a cytotoxicity assay. Results showed the NK cell cytotoxic activity in mice treated with 125 mg/kg ATR was significantly lower than that in the control group, but 5 mg/kg ATR and 25 mg/kg ATR did not significantly affect NK cell cytotoxicity. These results suggest that treatment with 125 mg/kg ATR for 28 days may induce NK cell dysfunction.
A lymphoproliferative assay provides information only about overall proliferative responses without detailing the specific cell subset involved in these responses. Expression of activation molecules prior to proliferation, on the other hand, offers a useful method to predict lymphocyte proliferative activity (33) . Exposure to foreign substances induces or stimulates a specific immune system. Some immune responses are directed to specific cells or cytokines that contribute to the immune response (34) . To better understand the immune environment after ATR treatment, whether the cell phenotypes obtained in flow cytometry are modulated or whether they provide a true reflection of these cells must be determined.
Lymphocyte subsets are major cellular components of the adaptive immune response (35) . CD3 is a signaling component of the TCR (T-cell receptor) complex, almost all T-lymphocytes express CD3, and therefore the CD3+ antibody is used as a genetic marker of T-lymphocytes. In addition, cytotoxic T lymphocytes express CD8 and recognize endogenous antigens by binding to MHC class I molecules; helper T-lymphocytes express CD4 and require the processing and presentation of antigens in association with MHC class II molecules by antigen-presenting cells and helper T-lymphocytes coordinate and assist other immune cells (36) . In order to determine if ATR decreased the yields of CD3+, CD4+, and CD8+ T lymphocytes, flow cytometry was used to detect surface markers of T lymphocyte subsets in this study. Interestingly, results indicated a significant decrease in the number of CD3+ T lymphocytes and a reduction in the ratio of CD4+/CD8+ T lymphocytes in the spleens of both mice treated with 25 mg/kg ATR and mice treated with 125 mg/kg ATR. A possible explanation for this is that ATR may affect T lymphocytes by decreasing CD4+ T lymphocytes mainly by affecting macrophage activation and production of cytokines (37) .
CD4+ T lymphocytes can be further subdivided by the patterns of cytokine expression. Th1 CD4+ T lymphocytes, involved in cellular immunity, are known to produce IL-2, IFN-γ, and TNF-α and enhance macrophage function, cellular immunity, and synthesis of opsonizing and complement-fixing antibodies. Th2 CD4+ T lymphocytes involved in humoral responses are known to enhance the immunoglobulin G-mediated response and activation of eosinophils through the actions of IL-4, IL-5, and IL-13 (36) . Numerous studies have found that the immune responses in mice and humans are critically influenced by the balance between Th1 and Th2 cytokines (38). Any absence in the cytokine network would cause an imbalance between Th1 and Th2 cytokines and potentially cause inflammation-related diseases. Inflammationrelated cytokines have been regarded as either proinflammatory or anti-inflammatory according to their contribution to the inflammatory response. Th1 cells express mainly pro-inflammatory cytokines, and Th2 cells primarily secrete anti-inflammatory cytokines. The current results indicated that 25 mg/kg ATR and 125 mg/kg ATR reduced serum IL-4 levels while the serum levels of IFN-γ, IL-2, and TNF-α remained unchanged. IL-4, produced particularly during allergic, cellular, and humoral responses to selected pathogen infections, may modulate other lymphoid cell activities such as regulation of the differentiation of antigen-stimulated T lymphocytes and control of immunoglobulin class switching in B lymphocytes (39) . Turnbull et al. found that IL-4 could inhibit macrophage cytokine production and restrain macrophage activation (40) . The current results demonstrated that ATR at a concentration higher than 25 mg/kg could alter the production of inflammation-related cytokines in serum. As a result, the balance between Th1 and Th2 immune responses might be disrupted.
The immunotoxicity of ATR manifests as a decrease in immune response capacity, including the suppression of immune cell function and atrophy of immune organs (10, 18) , which were also observed in the present study. The ATR concentrations in this study ranged from 5 mg/kg to 125 mg/kg, which were determined based on findings in previous studies (21, 41) and higher than what is expected in nature. However, these amounts ensured that the effects of ATR were noticeable in this study. In California, potential occupational exposure to ATR was assessed during mixing, loading, and application of ATR on field corn, and the absorbed daily dosage (ADD) of ATR for a mixer/loader/applicator was estimated to be 1.8-6.1 μg/kg/day in the event of short-term exposure (15-21 days) (9, 21) . However, the ADD of ATR is expected to be higher for commercial applicators and farmers in developing countries due to inappropriate personal protective equipment and unintentional overspraying. In the surface water in the East Liaohe River Basin of Jinlin Province, the average ATR content was 9.7 μg/L in regions with agricultural plots and 8.854 μg/L in regions without agricultural plots; ATR content was as high as 18.93 μg/L in July (42) . These data indicate that the daily ATR exposure for ordinary residents in the watershed is about 0.37-0.79 μg/kg/day, and this value is higher for farmers. ATR is not removed from the body within 24 h and its metabolites can still be detected in the urine 48 h after exposure (9) . Thus, some effects may occur after repeated exposures and result in accumulation of substances above a critical threshold.
Conclusions
This study found that ATR interferes with immune function by inducing degenerative changes in the spleen, inhibiting the proliferation of T lymphocytes and NK cell cytotoxic activity, decreasing the percentage of CD3+ and CD4+ T lymphocytes, and reducing the serum levels of IL-4. Results indicated that ATR may be associated with inflammation, infections, and other diseases. However, the many molecular mechanisms involved in this process are still unclear. Therefore, further studies are needed to elucidate the exact mechanisms underlying the deleterious effects of ATR on the immune system and to investigate the effects of prolonged exposure to ATR under natural conditions.
